Detection and Management of Geographic Disparities in the TOPCAT Trial: Lessons Learned and Derivative Recommendations - ScienceDirect
Prognostic Importance of Temporal Changes in Resting Heart Rate in Heart Failure and Preserved Ejection Fraction: From the TOPCAT Study | JACC: Heart Failure
CardsJC: PARAGON-HF Trial Journal Club - Cardionerds
Under-Enrollment of Obese Heart Failure with Preserved Ejection Fraction Patients in Major HFpEF Clinical Trials - Journal of Cardiac Failure
Spironolactone for Heart Failure with Preserved Ejection Fraction | NEJM
Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Manual of Operations
Detection and Management of Geographic Disparities in the TOPCAT Trial: Lessons Learned and Derivative Recommendations | JACC: Basic to Translational Science
Spectrum of epidemiological and clinical findings in patients with heart failure with preserved ejection fraction stratified by study design: a systematic review - Vaduganathan - 2016 - European Journal of Heart Failure - Wiley Online Library
Spironolactone for Heart Failure with Preserved Ejection Fraction | NEJM
Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: The TOPCAT Trial - ScienceDirect
Assessing the Eligibility Criteria in Phase III Randomized Controlled Trials of Drug Therapy in Heart Failure With Preserved Ejection Fraction: The Critical Play-Off Between a “Pure” Patient Phenotype and the Generalizability of
Spironolactone Metabolites in TOPCAT — New Insights into Regional Variation | NEJM
Abstract 278: Trends in Prescribing Patterns for Patients Hospitalized With Heart Failure With Preserved Ejection Fraction Before and After Clinical Trial Presentation | Circulation: Cardiovascular Quality and Outcomes
Weight changes in heart failure with preserved ejection fraction: findings from TOPCAT | SpringerLink
Detection and Management of Geographic Disparities in the TOPCAT Trial: Lessons Learned and Derivative Recommendations - ScienceDirect
Detection and Management of Geographic Disparities in the TOPCAT Trial: Lessons Learned and Derivative Recommendations | JACC: Basic to Translational Science
Regional Differences in Heart Failure With Preserved Ejection Fraction Trials | Circulation
Heart failure with preserved ejection fraction: present status and future directions | Experimental & Molecular Medicine
Frontiers | Clinical Implications of Plasma Galectin-3 in Heart Failure With Preserved Ejection Fraction: A Meta-Analysis
Pharmacoepidemiology | Free Full-Text | Spironolactone Utilization among Patients with Reduced and Preserved Ejection Fraction Heart Failure
Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial | Circulation
Machine learning models in heart failure with mildly reduced ejection fraction patients - Frontiers
Towards precision medicine in heart failure | Nature Reviews Cardiology
Spironolactone in Patients With Heart Failure, Preserved Ejection Fraction, and Worsening Renal Function - ScienceDirect
Rates of Spironolactone Initiation and Subsequent Hyperkalemia Hospitalizations in Patients with Heart Failure with Preserved Ejection Fraction Following the TOPCAT trial: A Cohort Study of Medicare Beneficiaries - Journal of Cardiac Failure
PDF) C2HEST score predicts clinical outcomes in heart failure with preserved ejection fraction: a secondary analysis of the TOPCAT trial
Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Protocols
Data-driven identification of heart failure disease states and progression pathways using electronic health records | Scientific Reports
